Biocytogen just stacked two cancer bets in three days. Is its platform strategy starting to compound?
Read More 7 minute read Gaming, Casino and Gambling Industry News Can Leifras’ $4 IPO survive Nasdaq volatility? Inside the Japanese education firm’s bold U.S. gamble Leifras is debuting on Nasdaq at $4 per ADS to raise $5M under ticker LFS. Find out if this Japanese micro-cap can attract global investors. byPallavi MadhirajuOctober 9, 2025